Abstract
The NHS newborn bloodspot screening programme screens all babies in England for five rare conditions. This study assessed the economics of expanding the screening programme to include five new inborn errors of the metabolism; HCU, MSUD, GA1, IVA, and LCHADD.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have